Lexicon Pharmaceuticals
LXRX
#6601
Rank
C$0.96 B
Marketcap
C$2.28
Share price
5.13%
Change (1 day)
248.43%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): C-$0.27

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.26. In 2024 the company made an earnings per share (EPS) of C-$0.89 an increase over its 2023 EPS that were of C-$1.11.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.27-69.41%
2024C-$0.89-20%
2023C-$1.1131.15%
2022C-$0.85-0%
2021C-$0.8510.91%
2020C-$0.76-145.08%
2019C$1.70-206.09%
2018C-$1.60-5.74%
2017C-$1.70-10.95%
2016C-$1.902640%
2015C-$0.06947-96.34%
2014C-$1.90-2.53%
2013C-$1.95-9.09%
2012C-$2.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$24.69-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.61-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.91-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.11 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$8.75-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.69 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.04 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.53-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$106.58 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA